ALEJANDRIA MEADOWS: Open Payments
NPI 1649035742 · GLEN BURNIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,428 in 211 payments from 23 companies in 2025. Trend: 2023 $0 · 2024 $1,908 · 2025 $5,428
Food & beverage: $5,229Education: $199
| Company | Payments | Amount |
|---|---|---|
| Organon LLC | 24 | $631 |
| LEO Pharma Inc. | 12 | $503 |
| Janssen Biotech, Inc. | 20 | $496 |
| Incyte Corporation | 13 | $450 |
| Regeneron Healthcare Solutions, Inc. | 14 | $369 |
| GENZYME CORPORATION | 9 | $352 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 19 | $351 |
| Galderma Laboratories, L.P. | 12 | $345 |
| Novartis Pharmaceuticals Corporation | 18 | $330 |
| ABBVIE INC. | 19 | $302 |
Products named: DUPIXENT, TREMFYA, VTAMA, OPZELURA, NEMLUVIO, COSENTYX, ADBRY, Bimzelx.
Industry payments across MD — which companies pay providers there.
